601-89-8 | Sigma-Aldrich

Quality Control Range Sheet- EQC-106 and EQC-206

IL-1a Control 1 289 – 601 pg/mL IFNy Control 1 2608 – 5417 pg/mL Control 2 1467 – 3048 pg/mL Control 2 12973 – 26943 pg/mL GM-CSF

Data Sheet - F2918

13, 785 (1993). 8. Zachary, I., and Rozengurt, E., Cell, 71, 891 (1992). 9. Gates, R., et al., Cell Growth Diff., 5, 891 (1994). 10. Sankar, S., et al., Am. J. Pathol., 147, 601 (1995). 11.

Data Sheet - C7613

1993). 8. Zachary, I., and Rozengurt, E., Cell, 71, 891- 894 (1992). 9. Gates, R., et al., Cell Growth Diff., 5, 891-899 (1994). 10. Sankar, S., et al., Am. J. Pathol., 147, 601-608 (1995)

Product Information Sheet-bgals-ro

1 ml Not available in US Cat. No. 03 707 598 001 5 ml Cat. No. 03 707 601 001 15 ml Store the product at +2 to +8°C. https://www.sigmaaldrich.com

Data Sheet - SAB4200695

502-07 (1997). 7. Duden, R., et al., Cell, 64, 649-65 (1991). 8. Jarvik, J.W., and Telmer, C.A., Annu. Rev. Genet., 32, 601-18 (1998). 9. Ohnishi S., Curr. Top. Membr. Transp., 32, 257-96

Systematic Optimization of Parameters Involved in Preparation of Chromatin and Chromatin Immunoprecipitation (ChIP) Workflow

H3 47-65 unmo d H3 47-65 K56ac H3 71-89 unmo d H3 71-89 K79me 1 H3 71-89 K79me 2 H3

XP725 Antibody Number-Lot Number 071M4826

.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83 84 1.4 13 14 15 16 37 38 39

Product Information Sheet - CS1010

assay. J. Biomol. Screen., 8, 89–95 (2003). 4. Hoffmann, K. et al., First non-radioactive assay for in vitro screening of histone deacetylase inhibitors. Pharmazie, 55, 601-606 (2000). 5. Wegener

AbSurance™ Histone Antibody Specificity Arrays

Y41P H3 47-65 unmod H3 47-65 K56ac H3 71-89 unmod H3 71-89 K79me1 H3 71-89 K79me2 H3 71-89

Product Information Sheet - MIDI26

7173 (2010). 8. Awan, F.T. et al., Blood, 115, 1204-1213 (2010). 9. Tario, J.D. Jr. et al., Meth. Mol. Biol., 699, 119-164 (2010). 10. Zaritskaya, L. et al., Expert Rev. Vaccines, 9, 601-616 (2010

Red Fluorescent Cell Linker Kits for General Cell Membrane Labeling

7173 (2010). 8. Awan, F.T. et al., Blood, 115, 1204-1213 (2010). 9. Tario, J.D. Jr. et al., Meth. Mol. Biol., 699, 119-164 (2010). 10. Zaritskaya, L. et al., Expert Rev. Vaccines, 9, 601-616 (2010

Guide to Chromatin Immunoprecipitation: Critical Factors for Success

47-65 K56ac H3 71-89 unmod H3 71-89 K79me1 H3 71-89 K79me2 H3 71-89 K79me3 Mouse IgG 10 ng Rabbit IgG 10 ng 10 ng

JULABO Catalog 2011 en

clamps for Erlenmeyer flaks 8 970 620 Base tray for assembling spring clamps on a mix and match basis 8 970 601 Spring clamp for 10 ml flasks 8 970 606 for 200-250 ml flasks 8 970

inNovations Newsletter #13

Novagen web site. Click one and see! 16 inNovations 13 ANNOUNCEMENTS Novagen, Inc. • 601 Science Dr. • Madison, WI 53711 Novagen ADDRESS CORRECTION REQUESTED Prices are subject to

Research Article: MCP-1, KC-like and IL-8 as critical mediators of

Min-Max 130–220 104–969 22–187 31–119 35–5019 1–2106 12–342 2–490 163–436 Median 143 330 89 51 601 461 111 145 224 SD 29 282 44 26 1477 527 110 180 95 Complicated day 1 (n = 18)

Neuroscience Product Selection Guide

Polymerase II 17-620 ChIPAb+™ SMRT 17-10057 ChIPAb+™ Sox-2, clone 6F1.2 17-656 ChIPAb+™ Sp1 17-601 ChIPAb+™ SUZ12 17-661 ChIPAb+™ TATA Binding Protein (TBP) 17-10098 ChIPAb+™ trimethyl-histone

Amidine-Based Catalysts (ABCs)- Design Development and Applications

Jr.; Miller, S. J. J. Am. Chem. Soc. 1999, 121, 11638. (b) Miller, S. J. Acc. Chem. Res. 2004, 37, 601. (7) (a) Wynberg, H.; Staring, E. G. J. J. Am. Chem. Soc. 1982, 104, 166. (b) Calter

inNovations Newsletter #14

processing Anthony Grabski1, Mark Mehler1, Don Drott1, and Jennifer Van Dinther2 — 1Novagen, Inc., 601 Science Dr., Madison, WI USA 53711, and 2PerkinElmer Life Sciences/Packard BioScience, 2200 Warrenville

XP725 Antibody List Lot 129K4831

hnRNP-L R4903 3191 HNRNPL M NP_001005335.1 y y n/d 371 hnRNP-U R6278 3192 HNRNPU M NP_004492.2 y n/d n/d 601 PRMT2 P0748 3275 PRMT2 M NP_001526.2 y n/d n/d 598 PRMT1 P6871 3276 PRMT1 P NP_001527.3 y n/d n/d 599

XP725 Antibody List Lot 129K4830

hnRNP-L R4903 3191 HNRNPL M NP_001005335.1 y y n/d 371 hnRNP-U R6278 3192 HNRNPU M NP_004492.2 y n/d n/d 601 PRMT2 P0748 3275 PRMT2 M NP_001526.2 y n/d n/d 598 PRMT1 P6871 3276 PRMT1 P NP_001527.3 y n/d n/d 599

XP725 Antibody List Lot 089K4791

hnRNP-L R4903 3191 HNRNPL M NP_001005335.1 y y n/d 371 hnRNP-U R6278 3192 HNRNPU M NP_004492.2 y n/d n/d 601 PRMT2 P0748 3275 PRMT2 M NP_001526.2 y n/d n/d 598 PRMT1 P6871 3276 PRMT1 P NP_001527.3 y n/d n/d 599

High fidelity gene amplification - PCR tools built for efficient and accurate gene discovery.

ChIP- Seq™ Kit (Catalogue No. 17-1010) and the ChIPAb+™ Sp1 antibody/ primer set (Catalogue No. 17-601). Libraries were constructed using 1 ng, 10 ng or an input chromatin sample and sequenced using

High fidelity gene amplification

ChIP- Seq™ Kit (Catalogue No. 17-1010) and the ChIPAb+™ Sp1 antibody/ primer set (Catalogue No. 17-601). Libraries were constructed using 1 ng, 10 ng or an input chromatin sample and sequenced using

Halal Certificate

FCC, FG W244007 B42148 HC-23SI8S32 600. ETHYL LAURATE 98%, FCC, FG W244104 A11780 HC-23SI3D21 601. ETHYL LEVULINATE 98%, FCC, FG W244201 B46245 HC-23SIAD65 602. ETHYL LEVULINATE, NATURAL, 98%, FG

Halal Certificate

FCC, FG W244007 B42148 HC-22SIBD53 600. ETHYL LAURATE 98%, FCC, FG W244104 A11780 HC-22SI5G42 601. ETHYL LEVULINATE 98%, FCC, FG W244201 B46245 HC-22SI8Q86 602. ETHYL LEVULINATE, NATURAL, 98%, FG

XP725 Worksheet for Lot Number 071M4826

Gemin3 G6544 599 4 1 3 7 GFAP Glial Fibrillary Acidic Protein G9269 600 4 1 3 8 GFAP Glial Fibrillary Acidic Protein G9269 601 4 1 4 1 GFAP G3893 602 4 1 4 2 GFAP G3893 603 4 1 4 3 Growth Factor

List of Antibodies

P5999 M n/d y y 598 PRMT1 P6871 P y n/d n/d 599 PRMT1 P6996 P y y y 600 Anti Cy3+Cy5 C0992 M NA NA NA 601 PRMT2 P0748 M y n/d n/d 602 PRMT3 P9370 M y y y 603 PRMT4 P4995 P y

XP725 Antibody List

y n/d n/d 599 PRMT1 P6996 15469, 3276 Prmt1,PRMT1 NP_062804.1,NP_938075.2 P y y y 600 Anti Cy3+Cy5 601 PRMT2 P0748 3275 PRMT2 NP_996845.1 M y n/d n/d 602 PRMT3 P9370 10196 PRMT3 NP_005779.1 M y y y 603

XP725 Antibody List 013M4793

n/d 599 PRMT1 P6996 15469, 3276 Prmt1,PRMT1 NP_062804.1,NP_938075.2 P y y y 600 Anti Cy3+Cy5 C0992 601 PRMT2 P0748 3275 PRMT2 NP_996845.1 M y n/d n/d 602 PRMT3 P9370 10196 PRMT3 NP_005779.1 M y y y 603